Cargando...
Optimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model
BACKGROUND: Influenza B virus infections remain insufficiently studied and antiviral management in immunocompromised patients is not well defined. The treatment regimens for these high-risk patients, which have elevated risk of severe disease-associated complications, require optimization and can be...
Guardado en:
| Publicado en: | J Antimicrob Chemother |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6477984/ https://ncbi.nlm.nih.gov/pubmed/30715325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dky560 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|